Refining Early Antitumoral Drug Development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Refining Early Antitumoral Drug Development

Published:2018-11 Issue:11 Volume:39 Page:922-925
ISSN:0165-6147
Container-title:Trends in Pharmacological Sciences
language:en
Short-container-title:Trends in Pharmacological Sciences

Author:

Ocaña Alberto,García-Alonso Sara,Amir Eitan,Pandiella Atanasio

Funder

Ministry of Economy and Competitiveness of Spain

Junta de Castilla y León

scientific foundation of the AECC

CRIS Foundation

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference17 articles.

1. Trial watch: phase II and phase III attrition rates 2011–2012;Arrowsmith;Nat. Rev. Drug Discov.,2013

2. Clinical approval success rates for investigational cancer drugs;DiMasi;Clin. Pharmacol. Ther.,2013

3. Small-molecule screens: a gateway to cancer therapeutic agents with case studies of Food and Drug Administration-approved drugs;Coussens;Pharmacol. Rev.,2017

4. Impact of high-throughput screening in biomedical research;Macarron;Nat. Rev. Drug Discov.,2011

5. Common pitfalls in preclinical cancer target validation;Kaelin;Nat. Rev. Cancer,2017

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumoral activity of a CDK12 inhibitor in colorectal cancer through a liposomal formulation;Biomedicine & Pharmacotherapy;2024-09

2. AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer;Nature Communications;2024-08-30

3. LncRNA-encoded peptides in cancer;Journal of Hematology & Oncology;2024-08-12

4. Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells;Frontiers in Immunology;2024-07-31

5. Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D;International Journal of Molecular Sciences;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3